export default function BpcOverviewPanel() {
  return (
    <div className="reta-overview">

      <p className="reta-overview__opener">
        BPC-157 is a short synthetic peptide derived from a protein found in stomach fluid, and it&rsquo;s the most talked-about recovery compound in the peptide community by a wide margin. Hundreds of animal studies show it accelerates healing of tendons, ligaments, gut lining, and even nerves &mdash; results that are genuinely impressive in rodent models. Human clinical evidence is nearly nonexistent. The gap between the animal data and the human evidence is real, and the sourcing chain is where most of the actual risk lives.
      </p>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 1</div>
        <h3 className="reta-overview__profile-heading">The Average Person &mdash; hurt, frustrated, and looking for something that actually works</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I&rsquo;ve had this tendon thing for six months, PT hasn&rsquo;t fixed it, and I keep seeing people online say BPC-157 healed them in weeks. Is this real?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The healing stories are everywhere</strong><br />Reddit, YouTube, and peptide forums are full of people reporting dramatic recovery from injuries that had plateaued &mdash; torn tendons, gut issues, joint pain, rotator cuffs. The anecdotes are vivid and specific. When you&rsquo;re stuck, that matters.</li>
          <li><strong>The animal research actually is impressive</strong><br />This isn&rsquo;t just bro science. There are hundreds of published animal studies from multiple research groups showing BPC-157 accelerates healing of tendons, muscles, gut lining, and bone. That&rsquo;s a real scientific signal, even if it&rsquo;s not yet proven in humans.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">No controlled human trial has proven BPC-157 works for injury recovery. The animal studies are promising &mdash; they don&rsquo;t lie about what happens in rats &mdash; but they also do not guarantee the same thing happens in you. People recover from injuries all the time, and if you&rsquo;re using BPC-157 while also resting, rehabbing, and eating well, attribution is genuinely hard. The bigger issue is what you&rsquo;re actually buying: gray-market peptide suppliers vary enormously in quality, and mislabeled or contaminated product is a documented problem. Net: the science is real enough to understand the excitement, but you&rsquo;re running a personal experiment without a reference map.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 2</div>
        <h3 className="reta-overview__profile-heading">The Athlete &mdash; stacking for faster recovery between training blocks</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I want to run BPC-157 subcutaneous for a partially torn ligament and maybe stack it with TB-500. What protocol makes sense and what should I actually watch for?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>Tendon and ligament data is the strongest in the literature</strong><br />Animal studies specifically on Achilles tendon transection, ACL repair, rotator cuff, and muscle tears consistently show accelerated healing with BPC-157. These are the exact injury types athletes deal with. The specificity of the animal evidence to athletic injury types is part of what makes the community enthusiasm understandable.</li>
          <li><strong>The BPC-157 + TB-500 stack has a mechanistic rationale</strong><br />BPC-157 is thought to improve tissue environment and growth factor signaling; TB-500 is thought to regulate actin and reduce inflammation through a different pathway. They don&rsquo;t overlap mechanistically &mdash; which is why the stack is popular. It&rsquo;s not just doubling up; it&rsquo;s combining complementary approaches.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The route choice matters for what you&rsquo;re targeting: subcutaneous injection distributes systemically, while injection near the injured site may concentrate locally (evidence for this is mostly theoretical, not validated). The 4-8 week protocols common in the community are derived from animal study timelines, not human trials. BPC-157 is not a structural repair agent &mdash; it creates a better healing environment, not a surgical fix. Stacking with another unverified compound doubles the sourcing risk surface. Net: mechanistically coherent, preclinically supported, but human evidence is sparse and sourcing is your actual risk variable.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 3</div>
        <h3 className="reta-overview__profile-heading">The Biohacker &mdash; tissue repair, gut optimization, neuro protection</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I want to understand the actual mechanisms &mdash; growth factor upregulation, angiogenesis, the gut-brain axis signaling &mdash; and figure out whether oral or injectable makes more sense for my specific goals.&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The mechanism depth is genuinely interesting</strong><br />BPC-157 appears to upregulate growth hormone receptor expression, promote angiogenesis through VEGF pathways, modulate nitric oxide synthesis, and interact with dopaminergic and serotonergic systems. It&rsquo;s a 15-amino-acid peptide with a disproportionately broad apparent mechanism footprint &mdash; which is either a sign of pleiotropic biology or an artifact of varied animal model designs, and the uncertainty itself is scientifically interesting.</li>
          <li><strong>The gut-brain axis angle adds longevity framing</strong><br />Oral BPC-157 specifically targets the gut lining and may survive gastric passage in sufficient concentrations for local GI effects. For biohackers interested in gut permeability, microbiome support, and the GI-brain axis, oral BPC-157 is a distinct application from the injectable repair use case &mdash; and the animal evidence for oral GI protection is actually among the stronger data.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The mechanism studies are mostly rodent, mostly from a small number of research groups, and the breadth of claimed effects should create some skepticism about whether all of them are real or some are noise. The oral bioavailability question &mdash; whether enough BPC-157 survives gastric digestion to produce systemic effects &mdash; is genuinely unresolved. For cancer history: the angiogenesis and growth factor promotion mechanisms are a real flag, not a theoretical one. No long-term human safety data exists for any use case. The absence of a pharmaceutical sponsor means this research gap may never close through conventional trials. Net: mechanistically rich, animal evidence solid, human evidence absent, and that gap is unlikely to close soon without your own n=1 data and rigorous sourcing.</p>
      </div>

      <div className="reta-overview__bottom">
        <p className="reta-overview__bottom-heading">The honest bottom line</p>
        <div className="reta-overview__bottom-cols">
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What BPC-157 is NOT</p>
            <ul className="reta-overview__bottom-list">
              <li>Proven to work in controlled human trials &mdash; no published human RCT for any indication</li>
              <li>A structural repair agent &mdash; it modulates healing environment, not a surgical substitute</li>
              <li>Risk-free because it&rsquo;s a peptide &mdash; sourcing contamination is the dominant real-world risk</li>
              <li>Equivalent from every supplier &mdash; product quality varies enormously without third-party verification</li>
              <li>Safe for people with active cancer or cancer history due to angiogenesis promotion mechanisms</li>
              <li>Something with established long-term human safety data at any dose</li>
            </ul>
          </div>
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What makes it interesting</p>
            <ul className="reta-overview__bottom-list">
              <li>30+ years of animal research from multiple independent groups &mdash; not just one lab&rsquo;s result</li>
              <li>Broad tissue specificity in animals: tendon, gut, muscle, bone, nerve &mdash; not a narrow effect</li>
              <li>Mechanistically distinct from other recovery compounds &mdash; not just anti-inflammatory</li>
              <li>Oral route has animal evidence for GI-specific effects that other peptides lack</li>
              <li>The gap between animal data and human evidence is a genuine scientific question, not settled</li>
            </ul>
          </div>
        </div>
      </div>

    </div>
  );
}
